| For: | Nakagawa K, Tsujinaka S, Katayose Y, Yambe K, Sakurai H, Takami K, Kondo N, Yamamoto K, Shibata C. Current insights and future perspectives of treatment strategies for biliary tract cancer. World J Gastrointest Oncol 2025; 17(10): 110415 [PMID: 41114096 DOI: 10.4251/wjgo.v17.i10.110415] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i10/110415.htm |
| Number | Citing Articles |
| 1 |
Fangfei Wang, Jinhao Li, Xin Zhao, Shaocheng Lyu, Qiang He. Combined Model of Inflammatory-Nutritional Indicators and Tumor Markers for Predicting Prognosis in Patients with Distal Cholangiocarcinoma: A Retrospective Cohort Study. Diseases 2026; 14(3) doi: 10.3390/diseases14030097
|
| 2 |
Lingyu Kong, Hongxin Piao. Multidimensional Regulatory Networks of Immune Resistance in Intrahepatic Cholangiocarcinoma: Synergistic Mechanisms of Tumor Microenvironment, Immune Cells, and Microbiota, and Novel Therapeutic Strategies. Gastrointestinal Disorders 2026; 8(3) doi: 10.3390/gidisord8030032
|
| 3 |
Kei Nakagawa, Hideaki Sato, Masahiro Iseki, Daisuke Douchi, Shuichi Aoki, Michiaki Unno. Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution. Exploration of Targeted Anti-tumor Therapy 2026; 7 doi: 10.37349/etat.2026.1002402
|